SMN2 pre-mRNA

Assets acting on this target.

Class
SMN2 splicing-modifying antisense oligonucleotide

By indication

Related mechanisms

SMN2 pre-mRNA drugs compared

2 drugs, stage by indication
2 drugs acting on SMN2 pre-mRNA: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
NusinersenSpinrazaBiogen, Ionis PharmaceuticalsantisenseApprovedApproved in Spinal Muscular Atrophy
Risdiplam (Evrysdi)EvrysdiGenentech (Roche Group), Rochesmall moleculeApprovedApproved in Spinal Muscular Atrophy

← all mechanisms